🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 9% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

35 Gram(s) Serving Size
26 Servings
Other Combinations Product Type
9% Evidence Coverage

Supplement Facts — Evidence Check

Calories
130 Calorie(s)
Total Fat
2 Gram(s) (3% DV)
Cholesterol
20 mg (7% DV)
Total Carbohydrates
4.5 Gram(s) (2% DV)
Protein
25 Gram(s) (50% DV)
Calcium
135 mg (10% DV)
95 mg (8% DV)
✅ Within RDA (0.1× RDA of 700 mg) 📚 12 studies (Tier A: 0, B: 3)
RDA 700mg This product: 95mg UL 4000mg
Sodium
100 mg (4% DV)
Potassium
165 mg (4% DV)
Lean Whey Protein Matrix
29 Gram(s)
Lean Whey Fat Metabolizing Matrix
3.3 Gram(s)

Other Ingredients

Sugar Corn Syrup modified Food Starch Dextrose Gelatin Sodium Hexametaphoshate Red #40 Aluminum Lake Yellow #6 Aluminum Lake Blue #1 Aluminum Lake Yellow #5 Aluminum Lake Natural & Artificial Flavors Gum Acacia Guar Gum Xanthan Gum Sucralose Sodium Caseinate Citric Acid Lactase

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (98% of products) Structure/Function (89% of products) Nutrient (76% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

⚠️ Warnings & Precautions

Warning: Very low calorie protein diets (below 400 calories per day) may cause serious illness or death. Do not use for weight reduction in such diets without medical supervision.

Not for use by infants, children, or pregnant or nursing women.

Not for use by infants, children, or pregnant or nursing women.

Discontinue use two weeks prior to surgery.

🧪 Formulation Notes

Fat metabolizing whey protein isolate

25G premium whey protein With CLA & L-Carnitine

Gourmet flavors

Lean Charms natural & artificial flavors

Warning: Contains dairy (whey), soy (lecithin) and tree nuts (coconuts). Allergen Warning: This product was produced on equipment which also processes dairy, soy, wheat, eggs, peanuts, and tree nuts.

Not a low calorie food.

Product Details

DSLD Entry Date 2022-08-23
Product Type Other Combinations
Form Powder
Brand MuscleSport
DSLD ID 272269
Data Updated 2026-04-11

Research Evidence

46 Research Sources
55 Avg Quality Score
23 Meta Analysis
7 Systematic Review
7 Rct
4 Clinical Trial
2 Other
1 Guideline
1 Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024
View all evidence for Phosphorus →

Compare Similar Products

View all Phosphorus products →